Skip to content

Moleculin Biotech, Inc.

MBRX

CIK 0001659617

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$61.96M
−28.8% YoY Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$23.42M
Q1 May 2026
Cash
$10.32M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
5.34M sh
Q1 May 2026

Revenue & Net Income

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings